Skip to content

Clinical efficacy study of visualized focused extracorporeal shock wave therapy for hemiplegic shoulder pain

Clinical efficacy study of visualized focused extracorporeal shock wave therapy for hemiplegic shoulder pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095316
Enrollment
Unknown
Registered
2025-01-06
Start date
2025-01-30
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiplegic shoulder pain

Interventions

Control group A (basic rehabilitation+ESWT sham stimulation group):On the basis of the same conventional basic rehabilitation treatment such as acupuncture and moxibustion, physical factors, and exerc
Experimental Group B (Basic Rehabilitation+Routine ESWT Group):On the basis of the same conventional basic rehabilitation treatment such as acupuncture and moxibustion, physical factors, and exercise
Experimental Group C (Basic Rehabilitation+Visual ESWT Group):On the basis of the same routine basic rehabilitation treatment such as acupuncture and moxibustion, physical factors, and exercise therap

Sponsors

Hengdian Wenrong Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1 The first onset meets the diagnostic criteria for stroke and is confirmed by CT or MRI 2 First occurrence of shoulder pain after hemiplegia, with a course of 0-12 months 3 Age range: 18-85 years old 4 After ultrasound imaging evaluation, the diagnosis was confirmed to be hemiplegic shoulder pain caused by musculoskeletal reasons, with a VAS score of >= 3 5 Voluntary signing of informed consent form

Exclusion criteria

Exclusion criteria: 1 Individuals with previous shoulder related diseases 2 Received shoulder joint pain treatment within 2 weeks prior to enrollment 3 Cognitive impairment, MoCA <= 20 points , uncooperative, unable to complete assessment 4 Patients with severe coagulation dysfunction 5 Patients with thrombosis and local infection in the treatment area 6 Unstable vital signs and increased risk of worsening of the condition

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale, VAS;

Secondary

MeasureTime frame
passive range of motion,PROM;Upper Fugl-Meyer Assessment Scale,U-FMA;High-frequency ultrasound;

Countries

China

Contacts

Public ContactGuo Kangxiang

Hengdian Wenrong Hospital

1247644060@qq.com+86 139 6790 4746

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026